Telomir Short Long Term Debt Total vs Total Current Liabilities Analysis
| TELO Stock | 3.98 0.30 7.01% |
Telomir Pharmaceuticals, financial indicator trend analysis is much more than just breaking down Telomir Pharmaceuticals, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telomir Pharmaceuticals, is a good investment. Please check the relationship between Telomir Pharmaceuticals, Short Long Term Debt Total and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Short Long Term Debt Total vs Total Current Liabilities
Short Long Term Debt Total vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telomir Pharmaceuticals, Short Long Term Debt Total account and Total Current Liabilities. At this time, the significance of the direction appears to have very week relationship.
The correlation between Telomir Pharmaceuticals,'s Short Long Term Debt Total and Total Current Liabilities is 0.23. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Telomir Pharmaceuticals, Common, assuming nothing else is changed. The correlation between historical values of Telomir Pharmaceuticals,'s Short Long Term Debt Total and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Telomir Pharmaceuticals, Common are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Short Long Term Debt Total i.e., Telomir Pharmaceuticals,'s Short Long Term Debt Total and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.23 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Short Long Term Debt Total
Total Current Liabilities
Total Current Liabilities is an item on Telomir Pharmaceuticals, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Telomir Pharmaceuticals, Common are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Telomir Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telomir Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Telomir Pharmaceuticals,'s Selling General Administrative is very stable compared to the past year. As of the 1st of December 2024, Issuance Of Capital Stock is likely to grow to about 1.2 M, while Enterprise Value Over EBITDA is likely to drop (19.05).
Telomir Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
Telomir Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Telomir Pharmaceuticals,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telomir Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.Moving together with Telomir Stock
| 0.88 | HLN | Haleon plc | PairCorr |
| 0.65 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.66 | ANRO | Alto Neuroscience, | PairCorr |
Moving against Telomir Stock
| 0.68 | FNMFO | Federal National Mortgage | PairCorr |
| 0.64 | KB | KB Financial Group | PairCorr |
| 0.62 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.54 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.49 | CIB | Bancolombia SA ADR | PairCorr |
The ability to find closely correlated positions to Telomir Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telomir Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telomir Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telomir Pharmaceuticals, Common to buy it.
The correlation of Telomir Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telomir Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telomir Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telomir Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.84) | Return On Equity (6.87) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.